Not Yet RecruitingPhase 1ACTRN12606000458538

Comparison of the effects of two marketed calcium preparations on reducing serum markers of bone resorption in post menopausal women

Comparison of the effects of two marketed Calcium preparations on reducing serum markers of bone resorption in post menopausal women

Sponsor

Institute of Medical and Veterinary Science, Frome road, Adelaide, SA 5000

Enrollment

25 participants

Start Date

Nov 1, 2006

Study Type

Interventional

Conditions

Healthy volunteers (post menopausal women)

Summary

Calcium supplementation has been shown to reduce the incidence of osteoporosis and related fractures. Currently Calsup (calcium carbonate) is marketed widely in Australia. This study is to compare the effects of Calsup with a newer calcium supplement, Citracal (Calcium citrate) on reducing serum markers of bone resorption. The hypothesis is that citracal may be equally effective in smaller doses and would have less side effects.

Eligibility

Sex: FemalesMin Age: 50 YearssMax Age: 55 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at: Comparison of the effects of two marketed calcium preparations on reducing serum markers of bone resorption in post menopausal women. It is open to women only, aged 50 to 55. To take part, you generally need: Post menopausal (menopause within last 5 years). There are also some health conditions and factors that may prevent you from joining.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A cross over trial using Calsup (calcium carbonate) 1000 mg and Citracal (calcium citrate) 500mg given as single doses orally, one week apart following base line serum tests.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000458538